Log in

MNOV MediciNova, Inc. NASDAQ · United States

MediciNova (MNOV) news

Top story · Sep 28, 2026 · SEC filing 8-K

MediciNova signs a material agreement

(the “Company”) amended its Lease (the “Lease”), dated July 20, 2021, between the Company and the Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026 (the “Amendment”), by and between the Company and Newport Gateway Office LLC.

Source: 8-K filed Sep 28, 2026 on SEC EDGAR

Latest MediciNova news

We have not published a story on MediciNova yet. When there is news, it will appear here.

MediciNova annual financials

LineFY2025FY2024
Research and development$6.7 million$6.8 million
Net income (loss)-$12.0 million-$11.0 million
Cash from operations-$9.8 million-$10.6 million
Cash and equivalents$30.8 million$40.4 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $25.4 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about MediciNova

What is the ticker symbol of MediciNova?

MediciNova, Inc. trades under the ticker MNOV on NASDAQ.

Where is MediciNova listed?

MediciNova, Inc. is listed on NASDAQ. Our directory also records these other listings: TSE:4875.

What is the SEC CIK of MediciNova?

The SEC Central Index Key (CIK) for MediciNova, Inc. is 1226616. Its filings are on SEC EDGAR.

How many shares does MediciNova have outstanding?

49,221,246 shares as of 2026-08-11, per the cover page of its 10-Q filed 2026-08-13.

Which country or territory is MediciNova listed under?

Our directory records MediciNova, Inc. under United States.

What does MediciNova do?

Our directory classifies MediciNova, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of MediciNova?

The ISIN recorded for MediciNova, Inc. is US58468P2065.

Does aibio.space cover MediciNova?

aibio.space lists MediciNova, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is MediciNova incorporated?

SEC records list its state or country of incorporation as DE.

Is MediciNova profitable?

MediciNova, Inc. reported a net loss of $12.0 million for the fiscal year ended Dec 31, 2025, and used $9.8 million of cash in operations, per its annual report to the SEC.

How much does MediciNova spend on research and development?

$6.7 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does MediciNova have?

$25.4 million in cash at Jun 30, 2026, per its 10-Q.

What is MediciNova's market cap?

We do not publish live share prices. In its annual report, MediciNova, Inc. put the market value of shares held by non-affiliates (public float) at $62.4 million as of Jun 30, 2025.

Is MediciNova a smaller reporting company?

SEC records list MediciNova, Inc.'s filer category as: Non-accelerated filer<br>Smaller reporting company.

Where is MediciNova headquartered?

SEC records list its business address as 4275 EXECUTIVE SQUARE, LA JOLLA, CA, 92037.

Investor discussion: MediciNova

Members talk about MediciNova (MNOV). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at MediciNova, newest first. Each line links the filing it comes from.

  1. Distress

    Reported the end of a material agreement. SEC Form 8-K (Items 1.02). Source

  2. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,9.01). Source

  3. Financings

    Set up an at-the-market program to sell shares over time. SEC Form S-3. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:MNOV on TradingView.

SEC filings and registration

SEC name
Medicinova Inc
CIK
1226616
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
MNOV (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
Non-accelerated filer<br>Smaller reporting company
Business address
4275 EXECUTIVE SQUARE, LA JOLLA, CA, 92037
Phone
858-373-1500
Shares outstanding
49,221,246 as of 2026-08-11 (10-Q filed 2026-08-13)

Recent filings (8-K and 6-K are the company's own announcements)

  • 8-K filed 2026-09-28
  • 8-K filed 2026-09-02
  • 8-K filed 2026-08-19
  • 10-Q filed 2026-08-13
  • 8-K filed 2026-06-24
  • 10-Q filed 2026-05-14
  • DEF 14A filed 2026-04-29
  • 10-K filed 2026-03-10

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

MediciNova, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MNOV, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MediciNova, Inc.
Ticker
MNOV
Listing
NASDAQ
Country or territory
United States
Business scope
Pharmaceuticals: Major
ISIN
US58468P2065
Other listed symbols
TSE:4875
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.